The Sumatriptan Succinate Tablets, cataloged under National Stock Number 6505-01-727-8704, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Mylan Pharmaceuticals Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-727-8704 |
| Primary Part Number | NDC00378-5632-59 |
| Item Name | Sumatriptan Succinate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Mylan Pharmaceuticals Inc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 9.0 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 100.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC51407-0013-09 | Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc (USA) |
| NDC00378-5632-59 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| 1683690 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM251292 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-727-8704 is a Sumatriptan Succinate Tablets, manufactured by Mylan Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-727-8704 has 2 manufacturer part numbers on file: NDC51407-0013-09 (Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc), NDC00378-5632-59 (Mylan Pharmaceuticals Inc).
Key specifications for NDC00378-5632-59: Administration: ORAL; Primary Container Content Quantity: 9.0 TABLETS; Primary Container Type: BOTTLE; Special Features: SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9 TABLETS. STORE AT 20 TO 25 C (68 TO 77 F). (SEE USP CONTROLLED ROOM TEMPERATURE). PROTECT FROM LIGHT. INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS.. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.